Viz LVO reveals its potential to assist in the early detection, triage, transfer, and treatment of LVO patients

The ALADIN Single Center Trial assessed the performance of Viz LVO on CTA imaging in 223 patients through a single center prospective cohort and retrospective analysis. With a maximum runtime of fewer than five minutes, Viz LVO detected ICA-T and MCA-M1 LVOs with an AUC of 0.91, as well as a sensitivity of 95.7% and specificity of 85.9%. To the best of our knowledge, this is the first A.I. algorithm for detecting intracranial LVOs.